Short-term longitudinal evaluation of cerebral blood flow in mild Alzheimer's disease

Neurological Sciences

Volumn 24, Issue 1, 2003, Pages 24-30

  Tonini, G ^a,b   Shanks, M F ^c   Venneri, A ^a,b  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF HULL   (United Kingdom)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Alzheimer's disease; Cerebral blood flow; Dementia; Longitudinal study

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

ADULT; ALZHEIMER DISEASE; ARTICLE; BRAIN BLOOD FLOW; BRAIN REGION; CLINICAL ARTICLE; CLINICAL TRIAL; CLUSTER ANALYSIS; COGNITIVE DEFECT; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; EARLY DIAGNOSIS; FEMALE; FRONTAL LOBE; HEMISPHERE; HUMAN; LONGITUDINAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; OUTPATIENT; PARIETAL LOBE; PROSPECTIVE STUDY; SENSITIVITY ANALYSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL PARAMETERS; TEMPORAL LOBE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CEREBROVASCULAR CIRCULATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0038446478     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100720300017     Document Type: Article

References (49)

1. DeCarli C (2001) The role of neuroimaging in dementia. Clin Geriatr Med 17:255-279
2. Frackowiak RSJ, Pozzilli C, Legg NJ, du Boulay GH, Marshall, J, Lenzi, GL, Jones T (1981) Regional cerebral oxygen supply and utilization in dementia: a clinical and physiological study with oxygen 15 and positron tomography. Brain 104:753-778
3. Fox NC, Freeborough PA, Rossor MN (1996) Visualisation and quantification of rates of atrophy in Alzheimer's disease. Lancet 348:94-97
4. Fox NC, Crum WR, Scahill RI, Stevens JM, Janssen JC, Rossor MN (2001) Imaging of onset and progression of Alzheimer's disease with voxel- compression mapping of serial magnetic resonance images. Lancet 358:201-205
5. Duara R, Grady C, Haxby J, Sundaram M, Cutler NR, Heston, L, Moore A, Schlageter N, Larson S, Rapoport SI (1986) Positron emission tomography in Alzheimer's disease. Neurology 36:879-887
6. Lehtovirta M, Kuikka J, Helisalmi S, Hartikainen P, Mannermaa A, Ryynanen M, Riekkinen P, Soininen H (1998) Longitudinal SPECT study in Alzheimer's disease: relation to apolipoprotein E polymorphism. J Neurol Neurosurg Psychiatry 64:742-746
7. Staff RT, Gemmell HG, Shanks MF, Murray AD, Venneri A (2000) Changes in the rCBF images of patients with Alzheimer's disease receiving Donepezil therapy. Nucl Med Commun 21:37-41
8. Venneri A, Shanks MF, Staff RT, Pestell SJ, Forbes KE, Gemmell HG, Murray AD (2002) Cerebral blood flow and cognitive responses to rivastigmine treatment in Alzheimer's disease. Neuroreport 13:83-87
9. Haxby JV, Grady CL, Koss E, Horwitz B, Heston L, Schapiro M, Friedland RP, Rapoport SI (1990) Longitudinal study of cerebral metabolic asymmetries and associated neuropsychological patterns in early dementia of the Alzheimer type. Arch Neurol 47:753-760
10. Smith GS, de Leon MJ, George AE, Kluger A, Volkow ND, McRae T, Golomb J, Ferris SH, Reisberg B, Ciaravino J et al (1992) Topography of cross-sectional and longitudinal glucose metabolic deficits in Alzheimer's disease. Pathophysiologic implications. Arch Neurol 49:1142-1150
11. Jagust WJ, Friedland RP, Budinger TF, Koss E, Ober B (1988) Longitudinal studies of regional cerebral metabolism in Alzheimer's disease. Neurology 38:909-912
12. Kogure D, Matsuda H, Ohnishi T, Asada T, Uno M, Kunihiro T, Nakano S, Takasaki M (2000) Longitudinal evaluation of early Alzheimer's disease using brain perfusion SPECT. J Nucl Med 41:1155-1162
13. Sachdev P, Gaur R, Brodaty H, Walker A, Meares S, Koder D, Haindl W (1997) Longitudinal study of cerebral blood flow in Alzheimer's disease using single photon emission tomography. Psychiatry Res 68:133-141
14. Brown DR, Hunter R, Wyper DJ, Patterson J, Kelly RC, Montaldi D, McCullouch J (1996) Longitudinal changes in cognitive function and regional cerebral function in Alzheimer's disease: a SPECT blood flow study. J Psychiatr Res 30:109-126
15. Pickut BA, Dierckx RA, Dobbeleir A, Audenaert K, Van Laere K, Vervaet A, De Deyn PP (1999) Validation of the cerebellum as a reference region for SPECT quantification in patients suffering from dementia of the Alzheimer type. Psychiatry Res 90:103-112
16. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34:939-944
17. Folstein MF, Folstein SE, McHugh PR (1975) Mini-Mental-State: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatry Research 12: 189-198
18. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gonbein J (1994) The neuropsychiatric inventory: Comprehensive assessment of psychopathology in dementia. Neurology 44:2308-2314
19. Bucks RS, Ashworth DL, Wilcock GK, Siegfried K (1996) Assessment of activities of daily living in dementia: development of the Bristol Activities of Daily Living Scale. Age Ageing 25:113-120
20. Yesavage T, Brink T, Rose T et al (1983) The development and validation of a geriatric depression screening scale. Journal of Psychiatric Research 17:37-49
21. Talairach J, Tournoux P (1988) Co-planar stereotaxic atlas of the human brain. Georg Thieme Verlag, Stuttgart
22. Friston KJ, Asburner J, Frith CD, Poline JB, Heather JD, Frackowiak RSI (1995) Spatial registration and normalisation of images. Human Brain Mapping 2:165-189
23. Friston K, Holmes A, Worsley K, Poline J, Frith C, Frackowiak RS (1995) Statistical parametric maps in functional imaging: a general linear approach. Human Brain Mapping 189-210
24. Talbot PR, Lloyd JL, Snowden JS, Neary D, Testa H (1994) Choice of reference region in the quantification of single-photon emission tomography in primary degenerative dementia. Eur J Nucl Med 21:503-508
25. Bartenstein P, Minoshima S, Hirsch C, Buck K, Willock F, Mosch D, Schad D, Schwaiger M, Kurz A (1997) Quantitative assessment of cerebral blood flow in patients with Alzheimer's disease by SPECT. J Nucl Med 38:1095-1101
26. Soonawala D, Amin T, Ebmeier KP, Steele JD, Dougall NJ, Best J, Migneco O, Nobili F, Scheidhauer K (2002) Statistical parametric mapping of (99m)Tc-HMPAO-SPECT images for the diagnosis of Alzheimer's disease: normalizing to cerebellar tracer uptake. Neuroimage 17:1193-1202
27. Venneri A, Turnbull OH, Della Sala S (1996) The taxonomic perspective: the neuropsychological diagnosis of dementia. European Review of Applied Psychology 46:179-190
28. Starkstein SE, Vazquez S (1997) SPECT findings in vascular dementia and Alzheimer's disease. In: PP De Deyn, R.A. Dierckx A, Alavi, BA Pickut (Eds) A textbook of SPECT in neurology and psyhicatry. John Libbey & Company Ltd., London, pp. 11-17
29. Deutsch G, Mountz, JM, Katholi CR, Liu HG, Harrell LE (1997) Regional stability of cerebral blood flow measured by repeated technetium-99m-HMPAO SPECT: implications for the study of state-dependent change. J Nucl Med 38:6-13
30. Braak E, Griffing K, Arai K, Bohl J, Bratzke H, Braak H (1999) Neuropathology of Alzheimer's disease: what is new since A. Alzheimer? Eur Arch Psychiatry Clin Neurosci 249:14-22
31. Haxby JV, Duara R, Grady CL, Cutler NR, Rapoport SI (1985) Relations between neuropsychological and cerebral metabolic asymmetries in early Alzheimer's disease. J Cereb Blood Flow Metab 5:193-200
32. Fox NC, Warrington EK, Rossor MN (1999) Serial magnetic resonance imaging of cerebral atrophy in preclinical Alzheimer's disease. Lancet 353:2125
33. Fox NC, Cousens S, Scahill R, Harvey RJ, Rossor MN (2000) Using serial registered brain magnetic resonance imaging to measure disease progression in Alzheimer disease: power calculations and estimates of sample size to detect treatment effects. Arch Neurol 57:339-344
34. Venneri A, Grassi F, Caffarra P (1996) Dementia of frontal lobe type: a report of the neuroimaging and neuropsychological results of a case study. Dementia 7:155-160
35. Jagust WJ (2000) Neuroimaging in dementia. Neurol Clin 18:885-902
36. Giacobini E (2000) Cholinesterase inhibitors stabilize Alzheimer's disease. Ann NY Acad Sci 920:321-327
37. Venneri A, Shanks MF (2002) Picturing dementia: experience with SPECT. 7th International Geneva/Springfield Symmposium on Advances in Alzheimer Therapy, Geneva, CH, pp 8-9
38. Nobili F, Koulibaly M, Vitali P, Migneco O, Mariani G, Ebmeier K, Pupi A, Robert PH, Rodriguez G, Darcourt J (2002) Brain perfusion follow-up in Alzheimer's patients during treatment with acetylcholinesterase inhibitors. J Nucl Med 43:983-990
39. Nordberg A (1996) Functional studies of new drugs for the treatment of Alzheimer's disease. Acta Neurol Scand Suppl 165:137-144
40. Mega MS, Cummings JL, O'Connor SM, Dinov ID, Reback E, Felix J, Masterman DL, Phelps ME, Small GW, Toga AW (2001) Cognitive and metabolic responses to metrifonate therapy in Alzheimer disease. Neuropsychiatry Neuropsychol Behav Neurol 14:63-68
41. Nakano S, Asada T, Matsuda H, Uno M, Takasaki M (2001) Donepezil hydrochloride preserves regional cerebral blood flow in patients with Alzheimer's disease. J Nucl Med 42:1441-1445
42. Potkin SG, Anand R., Fleming K, Alva G, Keator D, Carreon D, Messina J, Wu JC, Hartman R, Fallon JH (2001) Brain metabolic and clinical effects of rivastigmine in Alzheimer's disease. Int J Neuropsychopharmacol 4:223-230
43. Kasa P, Papp H, Kasa P Jr, Torok I (2000) Donepezil dose-dependently inhibits acetylcholinesterase activity in various areas and in the presynaptic cholinergic and the postsynaptic cholinoceptive enzyme-positive structures in the human and rat brain. Neuroscience 101: 89-100
44. Sokal RR, Rohly FS (1981) The principles and practices of statistics in Biological Research., Freeman and Company
45. Crawford JR, Howell DC (1998) Comparing an individuals test score against norms derived from small samples. The Clinical Neuropsychologist 12:482-486
46. Forbes KE, Venneri A (2003) A case for case: Handling letter case selection in written spelling. Neuropsychologia 41:1-9
47. de Leon MJ, Convit A, Wolf OT, Tarshish CY, DeSanti S, Rusinek H, Tsui W, Kandil E, Scherer AJ, Roche A, Imossi A, Thorn E, Bobinski M, Caraos C, Lesbre P, Schlyer D, Poirier J, Reisberg B, Fowler J (2001) Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/positron-emission tomography (FDG/PET). Proc Natl Acad Sci U S A 28:28
48. Arnaiz E, Jelic, V Almkvist O, Wahlund LO, Winblad B Valind S, Nordberg A (2001) Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment. Neuroreport 12:851-855
49. Almkvist O (2000) Functional brain imaging as a looking-glass into the degraded brain: reviewing evidence from Alzheimer disease in relation to normal aging. Acta Psychol (Amst) 105:255-277